Close Menu

NEW YORK – A US federal court will allow 10x Genomics to provide Vanderbilt University’s Vaccine Center with a new Chromium instrument configured to run GEM microfluidic chips to help respond to the 2019-nCoV coronavirus outbreak. 10x Genomics has been prohibited from selling so-called legacy instruments under an injunction issued by the US District Court for the District of Delaware, but the firm has been granted a one-time exception. Bio-Rad Laboratories, the plaintiff in the patent infringement suit that led to the injunction, agreed to the arrangement. Vanderbilt’s Vac

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.